CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
Bernstein Liebhard LLP, an investor rights law firm, reminded Capricor Therapeutics (NASDAQ: CAPR) investors of a September 28, 2026 deadline to seek lead plaintiff status in a securities fraud class action against the company. The suit covers investors who purchased Capricor securities between December 17, 2025 and July 6, 2026, and alleges the company and certain senior officers made materially false and misleading statements regarding business operations, growth prospects, and financial stability. This release is an attorney-advertising solicitation issued under the law firm's name, not a new disclosure from Capricor itself.
Key figures
- Class period end
- July 6, 2026
- Alleged violation
- Securities Exchange Act of 1934
- Class period start
- December 17, 2025
- Lead plaintiff deadline
- September 28, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.